Cargando…

Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been triall...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Fiona A, Katona, Lynda, Jefford, Michael, Smith, Allan Ben, Shaw, Joanne, Dhillon, Haryana M, Ellen, Steve, Phipps-Nelson, Jo, Lai-Kwon, Julia, Milne, Donna, Russell, Lahiru, Dax, Victoria, Diggens, Justine, Kent, Holly, Button-Sloan, Alison, Elliott, Jane, Shackleton, Mark, Burridge, Hayley, Ftanou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565154/
https://www.ncbi.nlm.nih.gov/pubmed/32937942
http://dx.doi.org/10.3390/jcm9092969
_version_ 1783595873292255232
author Lynch, Fiona A
Katona, Lynda
Jefford, Michael
Smith, Allan Ben
Shaw, Joanne
Dhillon, Haryana M
Ellen, Steve
Phipps-Nelson, Jo
Lai-Kwon, Julia
Milne, Donna
Russell, Lahiru
Dax, Victoria
Diggens, Justine
Kent, Holly
Button-Sloan, Alison
Elliott, Jane
Shackleton, Mark
Burridge, Hayley
Ftanou, Maria
author_facet Lynch, Fiona A
Katona, Lynda
Jefford, Michael
Smith, Allan Ben
Shaw, Joanne
Dhillon, Haryana M
Ellen, Steve
Phipps-Nelson, Jo
Lai-Kwon, Julia
Milne, Donna
Russell, Lahiru
Dax, Victoria
Diggens, Justine
Kent, Holly
Button-Sloan, Alison
Elliott, Jane
Shackleton, Mark
Burridge, Hayley
Ftanou, Maria
author_sort Lynch, Fiona A
collection PubMed
description Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease.
format Online
Article
Text
id pubmed-7565154
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75651542020-10-26 Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma Lynch, Fiona A Katona, Lynda Jefford, Michael Smith, Allan Ben Shaw, Joanne Dhillon, Haryana M Ellen, Steve Phipps-Nelson, Jo Lai-Kwon, Julia Milne, Donna Russell, Lahiru Dax, Victoria Diggens, Justine Kent, Holly Button-Sloan, Alison Elliott, Jane Shackleton, Mark Burridge, Hayley Ftanou, Maria J Clin Med Article Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease. MDPI 2020-09-14 /pmc/articles/PMC7565154/ /pubmed/32937942 http://dx.doi.org/10.3390/jcm9092969 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lynch, Fiona A
Katona, Lynda
Jefford, Michael
Smith, Allan Ben
Shaw, Joanne
Dhillon, Haryana M
Ellen, Steve
Phipps-Nelson, Jo
Lai-Kwon, Julia
Milne, Donna
Russell, Lahiru
Dax, Victoria
Diggens, Justine
Kent, Holly
Button-Sloan, Alison
Elliott, Jane
Shackleton, Mark
Burridge, Hayley
Ftanou, Maria
Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
title Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
title_full Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
title_fullStr Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
title_full_unstemmed Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
title_short Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
title_sort feasibility and acceptability of fear-less: a stepped-care program to manage fear of cancer recurrence in people with metastatic melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565154/
https://www.ncbi.nlm.nih.gov/pubmed/32937942
http://dx.doi.org/10.3390/jcm9092969
work_keys_str_mv AT lynchfionaa feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT katonalynda feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT jeffordmichael feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT smithallanben feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT shawjoanne feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT dhillonharyanam feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT ellensteve feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT phippsnelsonjo feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT laikwonjulia feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT milnedonna feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT russelllahiru feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT daxvictoria feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT diggensjustine feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT kentholly feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT buttonsloanalison feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT elliottjane feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT shackletonmark feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT burridgehayley feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma
AT ftanoumaria feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma